Treatment of eczema

Clinical Reviews in Allergy and Immunology

Volumn 33, Issue 3, 2007, Pages 204-225

  Chang, Christopher ^a   Keen, Carl L ^b   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atopic dermatitis; Food allergy; Immunoglobulin E; Immunotherapy; Soap

Indexed keywords

ALCLOMETASONE DIPROPIONATE; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; BETAMETHASONE DIPROPIONATE; CETIRIZINE; CHLORPHENIRAMINE; CLOBETASOL PROPIONATE; CLOBETASONE BUTYRATE; COAL TAR; CORTICOSTEROID; CORTISPORIN; DESONIDE; DIPHENHYDRAMINE; FLUTICASONE; HALCINONIDE; HYDROCORTISONE; HYDROCORTISONE 17 BUTYRATE 21 PROPIONATE; HYDROCORTISONE BUTYRATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LORATADINE; MOMETASONE FUROATE; MONTELUKAST; NICOTINIC ACID; PERMETHRIN; PRAMOCAINE; PSORALEN; PYRIDOXINE; TRIAMCINOLONE ACETONIDE; UNINDEXED DRUG; ZILEUTON;

ACUPUNCTURE; APPETITE; ASTHMA; ATOPIC DERMATITIS; BURN; CAPILLARY RESISTANCE; CATARACT; CLINICAL FEATURE; CLINICAL TRIAL; CONTACT DERMATITIS; CUSHING SYNDROME; DELAYED HYPERSENSITIVITY; DEPRESSION; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIET SUPPLEMENTATION; DIFFERENTIAL DIAGNOSIS; DISEASE CONTROL; DISEASE SEVERITY; DRUG ABSORPTION; DRY SKIN; ECZEMA; EXFOLIATIVE DERMATITIS; FOOD ALLERGY; GLAUCOMA; GROWTH RETARDATION; HALLUCINATION; HAND WASHING; HIRSUTISM; HUMAN; HUMIDIFIER; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; LIVER TOXICITY; MENSTRUATION DISORDER; MENTAL DISEASE; MOOD CHANGE; MYCOSIS FUNGOIDES; NAUSEA AND VOMITING; NICOTINIC ACID DEFICIENCY; NUMMULAR DERMATITIS; OSTEOPOROSIS; PEPTIC ULCER; PHOTOSENSITIVITY; PSORIASIS; PYRIDOXINE DEFICIENCY; RASH; REVIEW; RISK FACTOR; SCABIES; SEBORRHEIC DERMATITIS; SIDE EFFECT; SKIN ATROPHY; SKIN BIOPSY; SKIN TEST; SPA TREATMENT; ULTRAVIOLET RADIATION; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN; ZINC DEFICIENCY;

ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ALLERGENS; BREAST FEEDING; CHILD; CHILD, PRESCHOOL; COMPLEMENTARY THERAPIES; DIAGNOSIS, DIFFERENTIAL; ECZEMA; FEMALE; FOOD HYPERSENSITIVITY; FORECASTING; HISTAMINE H1 ANTAGONISTS; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOTHERAPY; INFANT; MIDDLE AGED; PHOTOTHERAPY; PHYTOTHERAPY; RISK FACTORS; SOAPS;

EID: 40749118917     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-007-0033-8     Document Type: Review

References (143)

1. Kaposi M (1895) Pathology and treatment of diseases of the skin. Wood, New York
2. Correale CE, Walker C, Murphy L, Craig TJ (1999) Atopic dermatitis: a review of diagnosis and treatment. Am Fam Phys 60:1191-1198, 1209-1110
3. Linneberg A, Simonsen JB,Petersen J,Stensballe LG,Benn CS (2006) Differential effects of risk factors on infant wheeze and atopic dermatitis emphasize a different etiology. J Allergy Clin Immunol 117:184-189
4. Hansen LG,Halken S,Host A,Moller K,Osterballe O (1993) Prediction of allergy from family history and cord blood IgE levels. A follow-up at the age of 5 years. Cord blood IgE. IV. Pediatr Allergy Immunol 4:34-40
5. Hansen LG,Host A,Halken S,Holmskov A,Husby S,Lassen LB,Storm K, Osterballe O (1992) Cord blood IgE. III. Prediction of IgE high-response and allergy. A follow-up at the age of 18 months. Allergy 47:404-410
6. Hansen LG, Host A, Halken S, Holmskov A, Husby S, Lassen LB, Storm K, Osterballe O (1992) Cord blood IgE. II. Prediction of atopic disease. A follow-up at the age of 18 months. Allergy 47:397-403
7. Hansen LG, Host A, Halken S, Holmskov A, Husby S, Lassen LB, Storm K, Osterballe O (1992) Cord blood IgE. I. IgE screening in 2814 newborn children. Allergy 47:391-396
8. European Task Force on Atopic Dermatitis (1993) Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 186:23-31
9. Wolkerstorfer A, de Waard van der Spek FB, Glazenburg EJ, Mulder PG, Oranje AP (1999) Scoring the severity of atopic dermatitis: three item severity score as a rough system for daily practice and as a pre-screening tool for studies. Acta Derm Venereol 79:356-359
10. Gelmetti C, Colonna C (2004) The value of SCORAD and beyond. Towards a standardized evaluation of severity? Allergy 59(Suppl 78):61-65
11. Silny W,Czarnecka-Operacz M,Silny P (2005) The new scoring system for evaluation of skin inflammation extent and severity in patients with atopic dermatitis. Acta Dermatovenerol Croat 13:219-224
12. Sugarman JL, Fluhr JW, Fowler AJ, Bruckner T, Diepgen TL,Williams ML (2003) The objective severity assessment of atopic dermatitis score: an objective measure using permeability barrier function and stratum corneum hydration with computer-assisted estimates for extent of disease. Arch Dermatol 139:1417-1422
13. Pucci N, Novembre E, Cammarata MG, Bernardini R, Monaco MG, Calogero C, Vierucci A (2005) Scoring atopic dermatitis in infants and young children: distinctive features of the SCORAD index. Allergy 60:113-116
14. Sprikkelman AB, Tupker RA, Burgerhof H, Schouten JP, Brand PL, Heymans HS, van Aalderen WM (1997) Severity scoring of atopic dermatitis: a comparison of three scoring systems. Allergy 52:944-949
15. Chandra RK, Puri S, Hamed A (1989) Influence of maternal diet during lactation and use of formula feeds on development of atopic eczema in high risk infants. BMJ 299:228-230
16. Chandra RK, Hamed A (1991) Cumulative incidence of atopic disorders in high risk infants fed whey hydrolysate, soy, and conventional cow milk formulas. Ann Allergy 67:129-132
17. Wijga AH, van Houwelingen AC, Kerkhof M, Tabak C, de Jongste JC, Gerritsen J, Boshuizen H, Brunekreef B, Smit HA (2006) Breast milk fatty acids and allergic disease in preschool children: the prevention and incidence of asthma and mite allergy birth cohort study. J Allergy Clin Immunol 117:440-447
18. Kull I, Bohme M, Wahlgren CF, Nordvall L, Pershagen G, Wickman M (2005) Breast-feeding reduces the risk for childhood eczema. J Allergy Clin Immunol 116:657-661
19. Odelram H, Vanto T, Jacobsen L, Kjellman NI (1996) Whey hydrolysate compared with cow's milk-based formula for weaning at about 6 months of age in high allergy-risk infants: effects on atopic disease and sensitization. Allergy 51:192-195
20. Tan BB, Weald D, Strickland I, Friedmann PS (1996) Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis. Lancet 347:15-18
21. Ricci G, Patrizi A, Specchia F, Menna L, Bottau P, D'Angelo V, Masi M (2000) Effect of house dust mite avoidance measures in children with atopic dermatitis. Br J Dermatol 143:379-384
22. Lever R, MacDonald C, Waugh P, Aitchison T (1998) Randomised controlled trial of advice on an egg exclusion diet in young children with atopic eczema and sensitivity to eggs. Pediatr Allergy Immunol 9:13-19
23. Sloper KS, Wadsworth J, Brostoff J (1991) Children with atopic eczema. II: Immunological findings associated with dietary manipulations. Q J Med 80:695-705
24. Reibel S, Rohr C, Ziegert M, Sommerfeld C, Wahn U, Niggemann B (2000) What safety measures need to be taken in oral food challenges in children? Allergy 55:940-944
25. Munkvad M (1989) A comparative trial of Clinitar versus hydrocortisone cream in the treatment of atopic eczema. Br J Dermatol 121:763-766
26. Kubota K, Machida I, Tamura K, Take H, Kurabayashi H, Akiba T, Tamura J (1997) Treatment of refractory cases of atopic dermatitis with acidic hot-spring bathing. Acta Derm Venereol 77:452-454
27. Ricci G, Patrizi A, Bendandi B, Menna G, Varotti E, M Masi (2004) Clinical effectiveness of a silk fabric in the treatment of atopic dermatitis. Br J Dermatol 150:127-131
28. Grundmann-Kollmann M, Behrens S, Podda M, Peter RU, Kaufmann R, Kerscher M (1999) Phototherapy for atopic eczema with narrow-band UVB. J Am Acad Dermatol 40:995-997
29. Ogawa H, Yoshiike T (1992) Atopic dermatitis: studies of skin permeability and effectiveness of topical PUVA treatment. Pediatr Dermatol 9:383-385
30. Devillers AC, Oranje AP (2006) Efficacy and safety of 'wet-wrap' dressings as an intervention treatment in children with severe and/or refractory atopic dermatitis: a critical review of the literature. Br J Dermatol 154:579-585
31. Hindley D, Galloway G, Murray J, Gardener L (2006) A randomised study of "wet wraps" versus conventional treatment for atopic eczema. Arch Dis Child 91:164-168
32. Stein L (2005) Clinical studies of a new vehicle formulation for topical corticosteroids in the treatment of psoriasis. J Am Acad Dermatol 53:S39-S49
33. Grove G, Zerweck C (2004) An evaluation of the moisturizing and anti-itch effects of a lactic acid and pramoxine hydrochloride cream. Cutis 73:135-139
34. Bernhardt DT (1991) Topical diphenhydramine toxicity. Wis Med J 90:469-471
35. Jorizzo J, Levy M, Lucky A, Shavin J, Goldberg G, Dunlap F, Hinds A, Strelka L, Baker M, Tuley M et al (1995) Multicenter trial for long-term safety and efficacy comparison of 0.05% desonide and 1% hydrocortisone ointments in the treatment of atopic dermatitis in pediatric patients. J Am Acad Dermatol 33:74-77
36. Sears HW, Bailer JW, Yeadon A (1997) Efficacy and safety of hydrocortisone buteprate 0.1% cream in patients with atopic dermatitis. Clin Ther 19:710-719
37. Van Der Meer JB, Glazenburg EJ, Mulder PG, Eggink HF, Coenraads PJ (1999) The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic Dermatitis Study Group. Br J Dermatol 140:1114-1121
38. Wolkerstorfer A, Strobos MA, Glazenburg EJ, Mulder PG, Oranje AP (1998) Fluticasone propionate 0.05% cream once daily versus clobetasone butyrate 0.05% cream twice daily in children with atopic dermatitis. J Am Acad Dermatol 39:226-231
39. Lucky AW, Grote GD, Williams JL, Tuley MR, Czernielewski JM, Dolak TM, Herndon JH, Baker MD (1997) Effect of desonide ointment, 0.05%, on the hypothalamic-pituitary-adrenal axis of children with atopic dermatitis. Cutis 59:151-153
40. Crespi HG (1986) Topical corticosteroid therapy for children: alclometasone dipropionate cream 0.05%. Clin Ther 8:203-210
41. Beattie PE, Lewis-Jones MS (2003) Parental knowledge of topical therapies in the treatment of childhood atopic dermatitis. Clin Exp Dermatol 28:549-553
42. Fukaya M (2000) Why do patients with atopic dermatitis refuse to apply topical corticosteroids? Dermatology 201:242-245
43. Ainley-Walker PF, Patel L, David TJ (1998) Side to side comparison of topical treatment in atopic dermatitis. Arch Dis Child 79:149-152
44. Woodmansee DP, Simon RA (1999) A pilot study examining the role of zileuton in atopic dermatitis. Ann Allergy Asthma Immunol 83:548-552
45. Pei AY, Chan HH, Leung TF (2001) Montelukast in the treatment of children with moderate-to-severe atopic dermatitis: a pilot study. Pediatr Allergy Immunol 12:154-158
46. Capella GL, Grigerio E, Altomare G (2001) A randomized trial of leukotriene receptor antagonist montelukast in moderate-to-severe atopic dermatitis of adults. Eur J Dermatol 11:209-213
47. Yanase DJ, David-Bajar K (2001) The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis. J Am Acad Dermatol 44:89-93
48. Chunharas A, Wisuthsarewong W, Wananukul S, Viravan S (2002) Therapeutic efficacy and safety of loratadine syrup in childhood atopic dermatitis treated with mometasone furoate 0.1 per cent cream. J Med Assoc Thai 85:482-487
49. Diepgen TL (2002) Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (the ETAC trial) over 18 months. Pediatr Allergy Immunol 13:278-286
50. Kawashima M, Tango T, Noguchi T, Inagi M, Nakagawa H, Harada S (2003) Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study. Br J Dermatol 148:1212-1221
51. Stander S, Steinhoff M (2002) Pathophysiology of pruritus in atopic dermatitis: an overview. Exp Dermatol 11:12-24
52. Wahlgren CF (1999) Itch and atopic dermatitis: an overview. J Dermatol 26:770-779
53. Rystedt I, Strannegard IL, Strannegard O (1986) Recurrent viral infections in patients with past or present atopic dermatitis. Br J Dermatol 114:575-582
54. Pauly CR, Artis WM, Jones HE (1978) Atopic dermatitis, impaired cellular immunity, and molluscum contagiosum. Arch Dermatol 114:391-393
55. Kolmer HL, Taketomi EA, Hazen KC, Hughs E, Wilson BB, Platts-Mills TA (1996) Effect of combined antibacterial and antifungal treatment in severe atopic dermatitis. J Allergy Clin Immunol 98:702-707
56. Brockow K, Grabenhorst P, Abeck D, Traupe B, Ring J, Hoppe U, Wolf F (1999) Effect of gentian violet, corticosteroid and tar preparations in Staphylococcus-aureus-colonized atopic eczema. Dermatology 199:231-236
57. Khobragade KJ (2005) Efficacy and safety of combination ointment "fluticasone propionate 0.005% plus mupirocin 2.0%" for the treatment of atopic dermatitis with clinical suspicion of secondary bacterial infection: an open label uncontrolled study. Indian J Dermatol Venereol Leprol 71:91-95
58. Ravenscroft JC, Layton AM, Eady EA, Murtagh MS, Coates P, Walker M, Cove JH (2003) Short-term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema. Br J Dermatol 148:1010-1017
59. Schachner LA, Lamerson C, Sheehan MP, Boguniewicz M, Mosser J, Raimer S, Shull T, Jaracz E (2005) Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study. Pediatrics 116:e334-e342
60. Staab D, Kaufmann R, Brautigam M, Wahn U (2005) Treatment of infants with atopic eczema with pimecrolimus cream 1% improves parents' quality of life: a multicenter, randomized trial. Pediatr Allergy Immunol 16:527-533
61. Paul C, Cork M, Rossi AB, Papp KA, Barbier N, de Prost Y (2006) Safety and tolerability of 1% pimecrolimus cream among infants: experience with 1133 patients treated for up to 2 years. Pediatrics 117:e118-e128
62. Simon D, Vassina E, Yousefi S, Braathen LR, Simon HU (2005) Inflammatory cell numbers and cytokine expression in atopic dermatitis after topical pimecrolimus treatment. Allergy 60:944-951
63. Hultsch T, Kapp A, Spergel J (2005) Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Dermatology 211:174-187
64. Schreiber SL, Crabtree GR (1992) The mechanism of action of cyclosporin A and FK506. Immunol Today 13:136-142
65. Miranda JM, Alvarez-Nemegyei J, Saavedra MA, Teran L, Galvan-Villegas F, Garcia-Figueroa J, Jara LJ, Barile L (2004) A randomized, double-blind, multicenter, controlled clinical trial of cyclosporine plus chloroquine vs. cyclosporine plus placebo in early-onset rheumatoid arthritis. Arch Med Res 35:36-42
66. Madhok R, Torley HI, Capell HA (1991) A study of the longterm efficacy and toxicity of cyclosporine A in rheumatoid arthritis. J Rheumatol 18:1485-1489
67. Cutler C, Antin JH (2006) Chronic graft-versus-host disease. Curr Opin Oncol 18:126-131
68. Hamid Q, Boguniewicz M, Leung DY (1994) Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 94:870-876
69. Mori A, Suko, M, Nishizaki Y, Kaminuma O, Matsuzaki G, Ito K, Etoh T, Nakagawa H, Tsuruoka N, Okudaira H (1994) Regulation of interleukin-5 production by peripheral blood mononuclear cells from atopic patients with FK506, cyclosporin A and glucocorticoid. Int Arch Allergy Immunol 104(Suppl 1):32-35
70. Salo H, Pekurinen M, Granlund H, Nuutinen M, Erkko P, Reitamo S (2004) An economic evaluation of intermittent cyclosporin A therapy versus UVAB phototherapy in the treatment of patients with severe atopic dermatitis. Acta Derm Venereol 84:138-141
71. Goujon C, Berard F, Dahel K, Guillot I, Hennino A, Nosbaum A, Saad N, Nicolas JF (2006) Methotrexate for the treatment of adult atopic dermatitis. Eur J Dermatol 16:155-158
72. Buckley DA, Baldwin P, Rogers S (1998) The use of azathioprine in severe adult atopic eczema. J Eur Acad Dermatol Venereol 11:137-140
73. Berth-Jones J, Takwale A, Tan E, Barclay G, Agarwal S, Ahmed I, Hotchkiss, K, Graham-Brown RA (2002) Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial. Br J Dermatol 147:324-330
74. Kuanprasert N, Herbert O, Barnetson RS (2002) Clinical improvement and significant reduction of total serum IgE in patients suffering from severe atopic dermatitis treated with oral azathioprine. Australas J Dermatol 43:125-127
75. Murphy LA, Atherton DJ (2003) Azathioprine as a treatment for severe atopic eczema in children with a partial thiopurine methyl transferase (TPMT) deficiency. Pediatr Dermatol 20:531-534
76. Meggitt SJ, Reynolds NJ (2001) Azathioprine for atopic dermatitis. Clin Exp Dermatol 26:369-375
77. Tan BB, Lear JT, Gawkrodger DJ, English JS (1997) Azathioprine in dermatology: a survey of current practice in the U.K. Br J Dermatol 136:351-355
78. Magina S, Barros MA, Ferreira JA, Mesquita-Guimaraes J (2003) Atopy, nickel sensitivity, occupation, and clinical patterns in different types of hand dermatitis. Am J Contact Dermat 14:63-68
79. Gritiyarangsan P, Sukhum A, Tresukosol P, Kullavanijaya P (1998) Topical PUVA therapy for chronic hand eczema. J Dermatol 25:299-301
80. Veien NK, Olholm Larsen, P, Thestrup-Pedersen, K, Schou G (1999) Long-term, intermittent treatment of chronic hand eczema with mometasone furoate. Br J Dermatol 140:882-886
81. Glover MT, Atherton DJ (1992) A double-blind controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with atopic eczema. Clin Exp Allergy 22:440-446
82. Leroy BP, Boden G, Jacquemin MG, Lachapelle JM, Saint-Remy JM (1992) Allergen-antibody complexes in the treatment of atopic dermatitis: preliminary results of a double-blind placebo-controlled study. Acta Derm Venereol Suppl (Stockh) 176:129-131
83. Leroy BP, Boden G, Lachapelle JM, Jacquemin MG, Saint-Remy JM (1993) A novel therapy for atopic dermatitis with allergen-antibody complexes: a double-blind, placebo-controlled study. J Am Acad Dermatol 28:232-239
84. Leroy BP, Jacquemin MG, Lachapelle JM, Saint-Remy JM (1995) Allergen-sensitive atopic dermatitis is improved by injections of allergen combined with F(ab′)2 fragments of specific antibodies. Br J Dermatol 132:599-603
85. Werfel T, Breuer K, Rueff F, Przybilla B, Worm M, Grewe M, Ruzicka T, Brehler R, Wolf H, Schnitker J, Kapp A (2006) Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy 61:202-205
86. Mastrandrea F, Serio G, Minelli M, Minardi A, Scarcia G, Coradduzza G, Parmiani S (2000) Specific sublingual immunotherapy in atopic dermatitis. Results of a 6-year follow-up of 35 consecutive patients. Allergol Immunopathol (Madr) 28:54-62
87. Krathen RA, Hsu S (2005) Failure of omalizumab for treatment of severe adult atopic dermatitis. J Am Acad Dermatol 53:338-340
88. Lane JE, Cheyney JM, Lane TN, Kent DE, Cohen DJ (2006) Treatment of recalcitrant atopic dermatitis with omalizumab. J Am Acad Dermatol 54:68-72
89. Jolles S (2002) A review of high-dose intravenous immunoglobulin treatment for atopic dermatitis. Clin Exp Dermatol 27:3-7
90. Noh G, Lozano F (2001) Intravenous immune globulin effects on serum-soluble CD5 levels in atopic dermatitis. Clin Exp Allergy 31:1932-1938
91. Paul C, Lahfa M, Bachelez H, Chevret S, Dubertret L (2002) A randomized controlled evaluator-blinded trial of intravenous immunoglobulin in adults with severe atopic dermatitis. Br J Dermatol 147:518-522
92. Huang JL, Lee WY, Chen LC, Kuo ML, Hsieh KH (2000) Changes of serum levels of interleukin-2, intercellular adhesion molecule-1, endothelial leukocyte adhesion molecule-1 and Th1 and Th2 cell in severe atopic dermatitis after intravenous immunoglobulin therapy. Ann Allergy Asthma Immunol 84:345-352
93. Noh G, Lee KY (1999) Intravenous immune globulin (i.v.IG) therapy in steroid-resistant atopic dermatitis. J Korean Med Sci 14:63-68
94. Drake LA, Fallon JD, Sober A (1994) Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. The Doxepin Study Group. J Am Acad Dermatol 31:613-616
95. Drake LA, Millikan LE (1995) The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin Study Group. Arch Dermatol 131:1403-1408
96. Hartmann M, Enk A (2005) Mycophenolate mofetil and skin diseases. Lupus 14(Suppl 1):s58-s63
97. Neuber K, Schwartz I, Itschert G, Dieck AT (2000) Treatment of atopic eczema with oral mycophenolate mofetil. Br J Dermatol 143:385-391
98. Grundmann-Kollmann M, Podda M, Ochsendorf F, Boehncke WH, Kaufmann R, Zollner TM (2001) Mycophenolate mofetil is effective in the treatment of atopic dermatitis. Arch Dermatol 137:870-873
99. Jarman ER, Kuba A, Montermann E, Bartlett RR, Reske-Kunz AB (1999) Inhibition of murine IgE and immediate cutaneous hypersensitivity responses to ovalbumin by the immunomodulatory agent leflunomide. Clin Exp Immunol 115:221-228
100. Schmitt J, Wozel G, Pfeiffer C (2004) Leflunomide as a novel treatment option in severe atopic dermatitis. Br J Dermatol 150:1182-1185
101. Hanifin JM, Chan SC, Cheng JB, Tofte SJ, Henderson WR Jr, Kirby DS, Weiner ES (1996) Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis. J Invest Dermatol 107:51-56
102. Griffiths CE, Van Leent EJ, Gilbert M, Traulsen J (2002) Randomized comparison of the type 4 phosphodiesterase inhibitor cipamfylline cream, cream vehicle and hydrocortisone 17-butyrate cream for the treatment of atopic dermatitis. Br J Dermatol 147:299-307
103. Shupack J, Stiller M, Meola T Jr, Orbuch P (1991) Papaverine hydrochloride in the treatment of atopic dermatitis: a double-blind, placebo-controlled crossover clinical trial to reassess safety and efficacy. Dermatologica 183:21-24
104. Baer RL (1985) Papaverine therapy in atopic dermatitis. J Am Acad Dermatol 13:806-808
105. Berth-Jones J, Graham-Brown RA (1990). Failure of papaverine to reduce pruritus in atopic dermatitis: a double-blind, placebo-controlled cross-over study. Br J Dermatol 122:553-557
106. Crocker IC, Townley RG, Khan MM (1996) Phosphodiesterase inhibitors suppress proliferation of peripheral blood mononuclear cells and interleukin-4 and -5 secretion by human T-helper type 2 cells. Immunopharmacology 31:223-235
107. Rola-Pleszczynski M, Blanchard R (1981) Abnormal suppressor cell function in atopic dermatitis. J Invest Dermatol 76:279-283
108. Horak E, Murr C, Streif W, Schroecksnadel K, Schennach H, Fuchs D (2006) Association between neopterin in cord blood, urinary neopterin in early childhood and the development of atopic dermatitis, asthma and hay fever. Pediatr Allergy Immunol 17:11-16
109. Reinhold U, Kukel S, Brzoska J, Kreysel HW (1993) Systemic interferon gamma treatment in severe atopic dermatitis. J Am Acad Dermatol 29:58-63
110. Hanifin JM, Schneider LC, Leung DY, Ellis CN, Jaffe HS, Izu AE, Bucalo LR, Hirabayashi SE, Tofte SJ, Cantu-Gonzales G et al (1993) Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol 28:189-197
111. Chan JL, Davis-Reed L, Kimball AB (2004) Counter-regulatory balance: atopic dermatitis in patients undergoing infliximab infusion therapy. J Drugs Dermatol 3:315-318
112. Jacobi A, Antoni C, Manger B, Schuler G, Hertl M (2005) Infliximab in the treatment of moderate to severe atopic dermatitis. J Am Acad Dermatol 52:522-526
113. Felix Berumen JA, Gonzalez Diaz SN, Canseco Gonzalez C, Arias Cruz A (2004) Use of alternative medicine in the treatment of allergic diseases. Rev Alerg Mex 51:41-44
114. Kay AB, Lessof MH (1992) Allergy. Conventional and alternative concepts. A report of the Royal College of Physicians Committee on Clinical Immunology and Allergy. Clin Exp Allergy 22(Suppl 3):1-44
115. Rautava S, Kalliomaki M, Isolauri E (2002) Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 109:119-121
116. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E (2003) Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361:1869-1871
117. Denburg JA, Hatfield HM, Cyr MM, Hayes L, Holt PG, Sehmi R, Dunstan, JA, Prescott SL (2005) Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatr Res 57:276-281
118. Dunstan JA, Mori TA, Barden A, Beilin LJ, Taylor AL, Holt PG, Prescott. SL (2003) Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. J Allergy Clin Immunol 112:1178-1184
119. Dunstan JA, Mori TA, Barden A, Beilin LJ, Taylor AL, Holt PG, Prescott SL (2003) Maternal fish oil supplementation in pregnancy reduces interleukin-13 levels in cord blood of infants at high risk of atopy. Clin Exp Allergy 33:442-448
120. Bordoni A, Biagi PL, Masi M, Ricci G, Fanelli C, Patrizi A, Ceccolini E (1988) Evening primrose oil (Efamol) in the treatment of children with atopic eczema. Drugs Exp Clin Res 14:291-297
121. Bamford JT, Gibson RW, Renier CM (1985) Atopic eczema unresponsive to evening primrose oil (linoleic and gamma-linolenic acids). J Am Acad Dermatol 13:959-965
122. Henz BM, Jablonska S, van de Kerkhof PC, Stingl G, Blaszczyk M, Vandervalk PG, Veenhuizen R, Muggli R, Raederstorff D (1999) Double-blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema. Br J Dermatol 140:685-688
123. Borrek S, Hildebrandt A, Forster J (1997) [Gamma-linolenic-acid-rich borage seed oil capsules in children with atopic dermatitis. A placebo-controlled double-blind study]. Klin Padiatr 209:100-104
124. Takwale A, Tan E, Agarwal S, Barclay G, Ahmed I, Hotchkiss K, Thompson JR, Chapman T, Berth-Jones J (2003) Efficacy and tolerability of borage oil in adults and children with atopic eczema: randomised, double blind, placebo controlled, parallel group trial. BMJ 327:1385
125. Balabolkin II, Gordeeva GF, Fuseva ED, Dzhunelov AB, Kalugina OL, Khamidova MM (1992) [Use of vitamins in allergic illnesses in children]. Vopr Med Khim 38:36-40
126. Mabin DC, Hollis S, Lockwood J, David TJ (1995) Pyridoxine in atopic dermatitis. Br J Dermatol 133:764-767
127. Hoppu U, Rinne M, Salo-Vaananen P, Lampi AM, Piironen V, Isolauri E (2005) Vitamin C in breast milk may reduce the risk of atopy in the infant. Eur J Clin Nutr 59:123-128
128. Tsoureli-Nikita E, Hercogova J, Lotti T, Menchini G (2002) Evaluation of dietary intake of vitamin E in the treatment of atopic dermatitis: a study of the clinical course and evaluation of the immunoglobulin E serum levels. Int J Dermatol 41:146-150
129. Fairris GM, Perkins PJ, Lloyd B, Hinks L, Clayton BE (1989) The effect on atopic dermatitis of supplementation with selenium and vitamin E. Acta Derm Venereol 69:359-362
130. Cakman I, Kirchner H, Rink L (1997) Zinc supplementation reconstitutes the production of interferon-alpha by leukocytes from elderly persons. J Interferon Cytokine Res 17:469-472
131. David TJ, Wells FE, Sharpe TC, Gibbs AC (1984) Low serum zinc in children with atopic eczema. Br J Dermatol 111:597-601
132. Boscolo P, Di Gioacchino M, Sabbioni E, Benvenuti F, Conti P, Reale M, Bavazzano P, Giuliano G (1999) Expression of lymphocyte subpopulations, cytokine serum levels, and blood and urinary trace elements in asymptomatic atopic men exposed to an urban environment. Int Arch Occup Environ Health 72:26-32
133. Laitinen K, Kalliomaki M, Poussa T, Lagstrom H, Isolauri E (2005) Evaluation of diet and growth in children with and without atopic eczema: follow-up study from birth to 4 years. Br J Nutr 94:565-574
134. Ewing CI, Gibbs AC, Ashcroft C, David TJ (1991) Failure of oral zinc supplementation in atopic eczema. Eur J Clin Nutr 45:507-510
135. Sevar R (2005) Audit of outcome in 455 consecutive patients treated with homeopathic medicines. Homeopathy 94:215-221
136. Smolle J (2003) Homeopathy in dermatology. Dermatol Ther 16:93-97
137. Sheehan MP, Atherton DJ (1992) A controlled trial of traditional Chinese medicinal plants in widespread non-exudative atopic eczema. Br J Dermatol 126:179-184
138. Sheehan MP, Atherton DJ (1994) One-year follow up of children treated with Chinese medicinal herbs for atopic eczema. Br J Dermatol 130:488-493
139. Keane FM, Munn SE, du Vivier AW, Taylor NF, Higgins EM (1999) Analysis of Chinese herbal creams prescribed for dermatological conditions. BMJ 318:563-564
140. McMenamy CJ, Katz RC, Gipson M (1988) Treatment of eczema by EMG biofeedback and relaxation training: a multiple baseline analysis. J Behav Ther Exp Psychiatry 19:221-227
141. Schachner L, Field T, Hernandez-Reif M, Duarte AM, Krasnegor J (1998) Atopic dermatitis symptoms decreased in children following massage therapy. Pediatr Dermatol 15:390-395
142. Stewart AC, Thomas SE (1995) Hypnotherapy as a treatment for atopic dermatitis in adults and children. Br J Dermatol 132:778-783
143. Holm EA, Wulf HC, Stegmann H, Jemec GB (2006) Life quality assessment among patients with atopic eczema. Br J Dermatol 154:719-725